7e Journée start-up innovantes du dispositif médical

May 10, 2022 | Paris, France

We are thrilled to announce that this year we will be joining 7e Journée start-up innovantes du dispositif médical by SNITEM as Gold Sponsors, exhibitors, speakers, and judges! This event will include multiple workshops and sessions focusing on regulatory, market access, financing, and R&D challenges that MedTech companies face.

Come and find us at stand G6 or connect with our attendees below!

Our workshop: Financement des dispositifs médicaux connectés en France en 2022 : état des lieux et perspectives

Alira Health’s workshop titled “Financement des dispositifs médicaux connectés en France en 2022 : état des lieux et perspectives” will take place from 11:40 AM to 12:40 PM CEST in Room 2 and will cover the following topics (description available in French):

  • Introduction : Quelle(s) définition(s) des DM connectées et les prémices de la prise en charge de la télésurveillance en France : Expérimentations ETAPES
  • Boite à outils pour préparer son financement : quelles questions se poser pour un financement adéquat de sa solution connectée
  • Etat des lieux en France : Publication des référentiels par la HAS autour de la télésurveillance / inscription en nom de marques / autres dispositifs type Article 51, …
  • Quid des autres pays ? Focus synthétique sur la situation dans d’autres pays type EU5
Our speaker
Elodie Lehmann

Elodie Lehmann

Associate Director - Market Access France, Alira Health Expert in pharma and biotech, Elodie focuses on care pathways optimization with a focus on local market access projects. Elodie holds a degree in Biotechnology Engineering from Polytech Marseille, France, and an MSc from Kedge Business School, France.
Our judge
Christophe Michel

Christophe Michel

Associate Director Medical Device and Connected Health, Alira Health Christophe joined SNITEM Jury to designate the 12 most promising start-up companies in the MedTech industry and to define the winner who will receive the SNITEM prize during 7e Journée start-up innovantes du dispositif médical.

Expert in clinical evaluation, clinical risk analysis, and HTA interactions, Christophe holds Master's Degree in Pharmacology, Clinical and Metabolic Pharmacology and Ph.D. in Biomedical Engineering.
Our delegates
Marc Nomaksteinsky

Marc Nomaksteinsky

Partner, Alira Health
Frederic Durand-Salmon

Frédéric Durand-Salmon

VP of Clinical Digital Solutions
Tabatha Bourgois

Tabatha Bourgois

Business Development Manager, Regulatory, Alira Health
Pierre Muguet

Pierre Muguet

Global Business Development Manager MedTech, Alira Health
Jonathann Rouimi

Jonathann Rouimi

Strategy Consultant, Alira Health
Marie Vaillant

Marie Vaillant

Associate Consultant, Alira Health
Sarah Sadeuk

Sarah Sadeuk

Junior Consultant, Alira Health
Margaux Casteur

Margaux Casteur

Healthcare Strategy Associate Consultant, Alira Health
Antoine Ewald

Antoine Ewald

Healthcare Strategy Consultant, Alira Health
Matteo Beretta

Matteo Beretta

Strategy and Transaction Consultant - Life Sciences, Alira Health
Marine Meyer

Marine Meyer

Consultant, Alira Health
Erwan Autin

Erwan Autin

Senior Consultant Market Access, Alira Health
Ons Ben Dhia

Ons Ben Dhia

Consultant, Alira Health

Related news

Events September 30, 2022
XV Congresso Nazionale Sihta
We are pleased to share that we will be joining as speakers and sponsors XV Congresso Nazionale Sihta, a key event for Italian Healthcare industry.
Digital Health Real-World Evidence
News September 27, 2022
AseBio and Alira Health Partner to Foster Market Access for Biotech Startups
Alira Health and AseBio, the Spanish Bioindustry Association, are joining forces to support Spanish biotech companies looking to enter new markets.
Biotech Market Access Startups
Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Events September 7, 2022
MDIC Annual Patient Forum 2022
We are pleased to share that we will be joining as speakers MDIC Annual Patient Forum 2022 – a key platform for the discussion of how to transform patient engagement throughout the(...)
Clinical Trials MedTech Patient Engagement
Publications September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
News September 6, 2022
Alira Health Expands North American Capabilities with the Acquisition of Artisan Healthcare Consulting
The acquisition of Artisan strengthens and extends Alira Health’s Market Access and Management Consulting advisory practices in North America and globally.
Biotech Market Access Pharma Therapeutics
Publications September 5, 2022
Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them
Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)
Biologics Clinical Drug Development
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.